Jyothy Labs (532926) Q4 21/22 earnings summary

Executive summary

• FY22 consolidated revenue rose 15.1% to ₹2,196 crore, while EBITDA fell 21.1% to ₹248.2 crore and PAT declined 16.5% to ₹159.1 crore amid sharp input-cost inflation.

• Market-share gains, wider distribution and cost efficiencies supported growth; gross margin fell to 41.6% from 47.1% YoY.

Financial highlights

• Consolidated revenue from operations increased 15.1% to ₹2,196 crore in FY22; reported EBITDA was ₹248.2 crore versus ₹314.5 crore, down 21.1%.

• Consolidated PAT was ₹159.1 crore versus ₹190.7 crore, down 16.5%; PBT before exceptional items declined 23.7% to ₹196.9 crore.

• Gross margin was 41.6% versus 47.1% YoY; operating EBITDA margin was 11.3% versus 16.5%.

• Advertisement and promotion expense increased 30.3% to ₹161.1 crore, equal to 7.3% of net sales.

Outlook and guidance

• Focus is on portfolio optimisation and volume-led growth, supported by brand investment, technology upgrades and stronger distribution, even where this requires a margin trade-off.

• Rural expansion plans include additional field staff and van and moped sales; a hybrid channel approach will serve both online and physical-store shoppers.

• Two liquid detergents launched in FY22; targeted efforts will support Ujala Liquid Detergent penetration and Henko Matic Liquid Detergent in premium markets.

• The FY23 industry outlook cited CRISIL’s ~12% FMCG growth forecast, with food inflation, commodity and freight costs, and international uncertainty remaining near-term challenges.